| Display title | Biology:Heptavalent botulism antitoxin |
| Default sort key | Heptavalent botulism antitoxin |
| Page length (in bytes) | 19,692 |
| Namespace ID | 3026 |
| Namespace | Biology |
| Page ID | 504289 |
| Page content language | en - English |
| Page content model | wikitext |
| Indexing by robots | Allowed |
| Number of redirects to this page | 0 |
| Counted as a content page | Yes |
| HandWiki item ID | None |
| Edit | Allow all users (infinite) |
| Move | Allow all users (infinite) |
| Page creator | imported>NBrushPhys |
| Date of page creation | 04:32, 12 February 2024 |
| Latest editor | imported>NBrushPhys |
| Date of latest edit | 04:32, 12 February 2024 |
| Total number of edits | 1 |
| Recent number of edits (within past 90 days) | 0 |
| Recent number of distinct authors | 0 |
Description | Content |
Article description: (description)
This attribute controls the content of the description and og:description elements. | The Botulism Antitoxin Heptavalent (A, B, C, D, E, F, G) - (Equine) (trade name BAT), made by Emergent BioSolutions Canada Inc. (formerly Cangene Corporation) – is a licensed, commercially available botulism anti-toxin that effectively neutralizes all seven known botulinum nerve toxin serotypes (types... |
